Cytokinetics to Detail Investment Prospects at Investor & Analyst Day on October 16, 2024
Oct 2, 2024
Biopharmaceutical Stock Market Invest
Natarajan Sethuraman, PhD, Elevated to President of R&D at Entrada Therapeutics
Sep 25, 2024
Natarajan Sethuraman, PhD, Elevated to President of R&D at Entrada Therapeutics
Sep 25, 2024
Psyence Biomed Details Corporate Milestones with Emphasis on Upcoming Phase II Operational Highlights
Sep 16, 2024
Cingulate Gears Up for NDA Filing as It Advances ADHD Medication Development
Sep 4, 2024
Belite Bio Welcomes Dr. Hendrik P. N. Scholl as New Chief Medical Officer
Sep 2, 2024
Belite Bio Appoints New Chief Medical Officer Amid Advancements in Retinal Disease Therapies
Sep 2, 2024
NewAmsterdam Pharma Announces Participation at Investor Events in September
Aug 30, 2024
Avicanna's Subsidiary Successfully Exports CGG Brand to Denmark
Aug 15, 2024
Silo Pharma Launches $2.1 Million Registered Direct Offering in Accordance with Nasdaq Standards
Jul 20, 2024
Cingulate Secures $1.86 Million Through Warrant Exercise
Jun 28, 2024
NeuroSense Therapeutics Faces Nasdaq Delisting
Jun 22, 2024
Liquidia to Showcase Its Pipeline with Seven Posters at the 7th World Symposium on Pulmonary Hypertension
Jun 19, 2024
Immuron CEO, Steven Lydeamore, Slated to Present at the Emerging Growth Conference
Jun 6, 2024
Bank of America Foresees Up to 200% Growth for Select 'Strong Buy' Stocks Amidst Bullish Market Sentiment
May 20, 2024
Belite Bio Aims for Stargardt Disease Treatment Breakthrough With Tinlarebant in Japan
Mar 23, 2024
Class Action Filed Against Ventyx Biosciences, Inc. Involving Investors
Mar 5, 2024
AbbVie Boosts Biologics Production with $223M Singapore Facility Investment
Jan 27, 2024
Cellectar Biosciences Achieves Milestone in CNS Lymphoma with Iopofosine I 131
Jan 22, 2024
GENFIT Anticipates Investor Attention with 2024 Financial Calendar Announcement
Jan 15, 2024
Molecular Partners AG Announces Key Developments at J.P. Morgan Healthcare Conference
Jan 8, 2024
Beyond the Famous Seven: Vertex Pharmaceuticals Emerges as a Top Investment Choice
Dec 9, 2023
Initiated Research on TRACON Pharmaceuticals TCON by Analysts
Nov 15, 2023
Cognition Therapeutics Reveals Key Pathways in Alzheimer's and Parkinson's Diseases via Sigma-2 Receptor Modulators
Nov 15, 2023
Molecular Partners AG to Showcase DARPin Therapeutic Advances at PEGS Europe Summit
Nov 14, 2023